Evoke Pharma (NASDAQ:EVOK) Coverage Initiated by Analysts at StockNews.com
StockNews.com began coverage on shares of Evoke Pharma (NASDAQ:EVOK – Free Report) in a report released on Tuesday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Evoke Pharma Stock Up 1.2 % EVOK stock opened at $1.64 on Tuesday. The company has a debt-to-equity ratio of 2.35, a current ratio […]